DAV expressed strong disappointment and concern over the VA’s new Interim Final Rule that could lower disability compensation for millions of disabled veterans. This regulation permits the VA to decrease disability ratings for veterans who use medications to manage their conditions or alleviate symptoms. DAV criticized the rule for ignoring previous court decisions that protect veterans’ rights, specifically citing Jones v. Shinseki and Ingram v. Collins. The process of developing this rule was described as closed and rushed, preventing veterans from offering significant feedback. The implications of this change are unclear, leaving over 6 million veterans—most of whom are on medication—uncertain about how their disability compensation might be affected.